中华放射肿瘤学杂志
  Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
2020, Vol. 29(10): 827-832    DOI: 10.3760/cma.j.cn113030-20190520-00186
The role of concurrent chemotherapy in intensity-modulated radiotherapy for patients with stage Ⅲ nasopharyngeal carcinoma
Wu Zheng1, Wang Lei2, Xie Dehuan3, Lyu Shaowen3, Su Yong3
1Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China;
2Department of Radiation Oncology, Shen Zhen People′s Hospital, Shenzhen 518020, China;
3Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, State Key Laboratory of Oncology in South China, Guangzhou 510060, China
Received 2019-05-20  Revised null
Supporting info
null
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn